Kahira Pharmaceuticals & Chemical Industries Company (EGX:CPCI)

EGX:CPCI Cash Flow Statement

Financials in millions EGP. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Net Income	403.08	246.11	97.09	165.74	124.3	109.14
Depreciation & Amortization	36.31	19.84	15.94	-	-	0.65
Other Amortization	0.01	0.01	0.01	-	-	-
Other Operating Activities	-8.18	-3.08	-24.52	-113.92	37.95	-131.75
Operating Cash Flow	431.22	262.89	88.53	51.83	162.25	-21.96
Operating Cash Flow Growth	122.02%	196.96%	70.82%	-68.06%	-	-
Capital Expenditures	-196.07	-243.54	-79.07	-17.31	-23.68	-8.34
Sale of Property, Plant & Equipment	-0.55	-	0.08	0	0.04	-
Investment in Securities	-	-0.84	-	15.86	-14.11	14.47
Other Investing Activities	21.64	12.8	2.85	4.94	2.62	2.28
Investing Cash Flow	-174.98	-231.58	-76.14	3.49	-35.13	8.41
Long-Term Debt Issued	-	133.88	144.31	-	-	-
Long-Term Debt Repaid	-	-50.76	-28.36	-	-	-
Net Debt Issued (Repaid)	-50.87	83.12	115.95	-	-	-
Common Dividends Paid	-184.78	-85.53	-100.82	-75.2	-77.73	-54.95
Financing Cash Flow	-235.65	-2.41	15.13	-75.2	-77.73	-54.95
Net Cash Flow	20.59	28.9	27.51	-19.89	49.39	-68.5
Free Cash Flow	235.16	19.35	9.45	34.52	138.57	-30.3
Free Cash Flow Growth	1826.11%	104.69%	-72.61%	-75.09%	-	-
Free Cash Flow Margin	12.80%	1.42%	0.94%	3.10%	13.05%	-3.00%
Free Cash Flow Per Share	15.75	1.30	0.63	2.31	9.28	-2.03
Cash Interest Paid	21.87	20.21	5.85	-	-	-
Cash Income Tax Paid	83.11	45.89	73.12	51.33	36.22	36.35
Levered Free Cash Flow	192.37	-55.03	57.94	-20.17	97.35	-51.72
Unlevered Free Cash Flow	199.88	-43.19	60.12	-20.17	97.35	-51.72
Change in Net Working Capital	-39.13	-1.94	-75.27	122.91	-23.32	130.76

Source: S&P Global Market Intelligence. Standard template. Financial Sources.